Free Trial
→ 70%, 80%, 90% Win Rates? Grab Your Free Cheatsheets Today! (From WealthPress) (Ad) Free ARWR Stock Alerts

Arrowhead Pharmaceuticals (ARWR) SEC Filings & 10K Form

Arrowhead Pharmaceuticals logo
$19.90 -1.06 (-5.06%)
Closing price 04:00 PM Eastern
Extended Trading
$19.91 +0.01 (+0.05%)
As of 07:27 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Arrowhead Pharmaceuticals SEC Filings

Export to Excel
DateFilerForm TypeView
02/14/2025
8:31 AM		Arrowhead Pharmaceuticals (Subject)
Avoro Capital Advisors LLC (Filed by)
Form SCHEDULE 13G/A
02/10/2025
5:23 PM		Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2025
4:57 PM		Arrowhead Pharmaceuticals (Issuer)
INGRAM DOUGLAS S (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/07/2025
4:57 PM		Arrowhead Pharmaceuticals (Issuer)
INGRAM DOUGLAS S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
5:41 AM		Arrowhead Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
Form SCHEDULE 13G
01/27/2025
6:22 PM		Arrowhead Pharmaceuticals (Issuer)
OLUKOTUN ADEOYE Y (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
3:43 PM		Arrowhead Pharmaceuticals (Subject)
OLUKOTUN ADEOYE Y (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/07/2025
8:27 PM		Arrowhead Pharmaceuticals (Issuer)
Myszkowski Kenneth Allen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
8:28 PM		Arrowhead Pharmaceuticals (Issuer)
O'Brien Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
8:28 PM		Arrowhead Pharmaceuticals (Issuer)
Hamilton James C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
3:49 PM		Arrowhead Pharmaceuticals (Subject)
Myszkowski Kenneth Allen (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/07/2025
4:01 PM		Arrowhead Pharmaceuticals (Subject)
Myszkowski Kenneth Allen (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/07/2025
3:31 PM		Arrowhead Pharmaceuticals (Subject)
O'Brien Patrick (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/06/2025
5:07 PM		Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
4:48 PM		Arrowhead Pharmaceuticals (Subject)
Myszkowski Kenneth Allen (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/06/2025
4:33 PM		Arrowhead Pharmaceuticals (Subject)
Myszkowski Kenneth Allen (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/06/2025
4:40 PM		Arrowhead Pharmaceuticals (Subject)
Myszkowski Kenneth Allen (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/06/2025
4:26 PM		Arrowhead Pharmaceuticals (Subject)
Myszkowski Kenneth Allen (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/06/2025
4:19 PM		Arrowhead Pharmaceuticals (Subject)
Hamilton James C (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/06/2025
4:05 PM		Arrowhead Pharmaceuticals (Subject)
O'Brien Patrick (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/02/2025
3:16 PM		Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/30/2024
4:12 PM		Arrowhead Pharmaceuticals (Issuer)
OLUKOTUN ADEOYE Y (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2024
3:23 PM		Arrowhead Pharmaceuticals (Subject)
OLUKOTUN ADEOYE Y (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/23/2024
3:39 PM		Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2024
3:16 PM		Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/20/2024
5:04 PM		Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2024
5:04 PM		Arrowhead Pharmaceuticals (Issuer)
Lu Hongbo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2024
5:04 PM		Arrowhead Pharmaceuticals (Issuer)
PERRY MICHAEL S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2024
5:04 PM		Arrowhead Pharmaceuticals (Issuer)
Ferrari Mauro (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2024
5:05 PM		Arrowhead Pharmaceuticals (Issuer)
Waddill William D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2024
5:05 PM		Arrowhead Pharmaceuticals (Issuer)
OLUKOTUN ADEOYE Y (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2024
5:05 PM		Arrowhead Pharmaceuticals (Issuer)
Vakiener Victoria (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2024
5:15 PM		Arrowhead Pharmaceuticals (Issuer)
Vakiener Victoria (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2024
5:18 PM		Arrowhead Pharmaceuticals (Issuer)
GIVEN DOUGLAS B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2024
5:19 PM		Arrowhead Pharmaceuticals (Issuer)
Waddill William D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2024
3:41 PM		Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/17/2024
4:06 PM		Arrowhead Pharmaceuticals (Subject)
GIVEN DOUGLAS B (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/17/2024
3:53 PM		Arrowhead Pharmaceuticals (Subject)
Waddill William D. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/16/2024
3:44 PM		Arrowhead Pharmaceuticals (Subject)
Waddill William D. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/16/2024
3:15 PM		Arrowhead Pharmaceuticals (Subject)
GIVEN DOUGLAS B (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/15/2024
7:34 PM		Arrowhead Pharmaceuticals (Issuer)
Lu Hongbo (Reporting)
Form 5
Annual statement of changes in beneficial ownership of securities  
Grab This Altcoin Before Trump's Crypto Announcement (Ad)

Grab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which is why I'm recommending ONE coin to all investors right now.

Click here to check it out now
11/14/2024
8:38 AM		Arrowhead Pharmaceuticals (Subject)
Avoro Capital Advisors LLC (Filed by)
Form SC 13G
10/16/2024
8:15 AM		Arrowhead Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
07/03/2024
4:27 PM		Arrowhead Pharmaceuticals (Issuer)
Oliver Tracie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2024
3:09 PM		Arrowhead Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/06/2024
5:04 PM		Arrowhead Pharmaceuticals (Issuer)
Vakiener Victoria (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2024
1:39 PM		Arrowhead Pharmaceuticals (Subject)
Vakiener Victoria (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/10/2024
1:03 PM		Arrowhead Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
04/03/2024
5:05 PM		Arrowhead Pharmaceuticals (Issuer)
Hamilton James C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2024
3:30 PM		Arrowhead Pharmaceuticals (Subject)
Hamilton James C (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/20/2024
6:06 PM		Arrowhead Pharmaceuticals (Issuer)
Lu Hongbo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2024
3:38 PM		Arrowhead Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2024
6:00 PM		Arrowhead Pharmaceuticals (Issuer)
Lu Hongbo (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/08/2024
4:54 PM		Arrowhead Pharmaceuticals (Issuer)
Myszkowski Kenneth Allen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
4:30 PM		Arrowhead Pharmaceuticals (Subject)
Myszkowski Kenneth Allen (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:ARWR) was last updated on 2/21/2025 by MarketBeat.com Staff
From Our Partners
Collect $7k per month from Tesla’s SECRET dividend
Tesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...
Investors Alley | Sponsored
Elon “obliterates” Bill Gates?
All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...
Altimetry | Sponsored
NVDA Crash Update
An overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...
Chaikin Analytics | Sponsored
Has Trump finally met his match?
Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...
Behind the Markets | Sponsored
$2 Trillion Disappears Because of Fed's Secretive New Move
$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...
Stansberry Research | Sponsored
Is Starlink Set For The Largest IPO In History?
He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...
Paradigm Press | Sponsored
My 2025 AI Blueprint
I first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...
Weiss Ratings | Sponsored
Better than Bitcoin – and potentially more profitable
The world is obsessed with Bitcoin again... And for a good reason: It just soared beyond $100,000. Bitcoin ...
Brownstone Research | Sponsored